Barclays
BBNX

Barclays’s Beta Bionics BBNX Stock Holding History

Barclays’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$234K Buy
14,936
+7,592
+103% +$90.3K ﹤0.01% 3614
2026
Q1 		$73.6K Sell
7,344
-53,320
-88% -$789K ﹤0.01% 4157
2025
Q4 		$1.85M Buy
60,664
+6,250
+11% +$167K ﹤0.01% 2993
2025
Q3 		$1.08M Buy
54,414
+31,734
+140% +$558K ﹤0.01% 3317
2025
Q2 		$330K Buy
22,680
+5,255
+30% +$74.4K ﹤0.01% 3994
2025
Q1 		$213K Buy
+17,425
New +$325K ﹤0.01% 4004

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Barclays's BBNX Position: Q2 2026 in Review

Barclays increased its Beta Bionics (BBNX) stake by 103% in Q2 2026, buying an estimated $90.3K and bringing the position to 14,936 shares worth $234K. The position accounts for ﹤0.01% of the portfolio, ranked #3614.

Barclays first reported a position in BBNX in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.85M in Q4 2025. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Barclays held 14,936 shares of Beta Bionics worth $234K as of Q2 2026.
  • Barclays bought 7,592 Beta Bionics shares in Q2 2026, an estimated $90.3K.
  • Beta Bionics made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3614 holding.
  • Barclays first reported a position in Beta Bionics in Q1 2025 and has held it in 6 quarters since.
  • Barclays's Beta Bionics position peaked at $1.85M in Q4 2025.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.